These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21695927)

  • 1. [Blood lipid changes at long-term antiretroviral treatment].
    Snopková S; Jarkovský J; Matýsková M; Povolná K; Polák P; Cvanová M; Husa P
    Vnitr Lek; 2011 May; 57(5):463-71. PubMed ID: 21695927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda.
    Mills EJ; Bakanda C; Birungi J; Mwesigwa R; Chan K; Ford N; Hogg RS; Cooper C
    AIDS; 2011 Mar; 25(6):851-5. PubMed ID: 21330903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients.
    Burgard M; Boufassa F; Viard JP; Garrigue I; Ruffault A; Izopet J; Vabret A; Descamps D; Colson P; Seigneurin JM; Rouzioux C;
    AIDS; 2009 Oct; 23(16):2165-71. PubMed ID: 19657270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy.
    Bakanda C; Birungi J; Mwesigwa R; Ford N; Cooper CL; Au-Yeung C; Chan K; Nachega JB; Wood E; Hogg RS; Dybul M; Mills EJ
    AIDS; 2011 Mar; 25(5):701-5. PubMed ID: 21160412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.
    Mocroft A; Ledergerber B; Zilmer K; Kirk O; Hirschel B; Viard JP; Reiss P; Francioli P; Lazzarin A; Machala L; Phillips AN; Lundgren JD;
    AIDS; 2007 Sep; 21(14):1867-75. PubMed ID: 17721094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002.
    Lampe FC; Gatell JM; Staszewski S; Johnson MA; Pradier C; Gill MJ; de Lazzari E; Dauer B; Youle M; Fontas E; Krentz HB; Phillips AN
    Arch Intern Med; 2006 Mar; 166(5):521-8. PubMed ID: 16534038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment.
    Murillo W; de Rivera IL; Parham L; Jovel E; Palou E; Karlsson AC; Albert J
    HIV Med; 2010 Feb; 11(2):95-103. PubMed ID: 19686436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention.
    Toro PL; Katyal M; Carter RJ; Myer L; El-Sadr WM; Nash D; Abrams EJ;
    AIDS; 2010 Feb; 24(4):515-24. PubMed ID: 19996939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implant orthopaedic surgery in HIV asymptomatic carriers: management and early outcome.
    Bahebeck J; Eone DH; Nonga BN; Kingue TN; Sosso M
    Injury; 2009 Nov; 40(11):1147-50. PubMed ID: 19467653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipid profile in highly active antiretroviral therapy-naïve HIV-infected patients in Cameroon: a case-control study.
    Nguemaïm NF; Mbuagbaw J; Nkoa T; Alemnji G; Této G; Fanhi TC; Asonganyi T; Samé-Ekobo A
    HIV Med; 2010 Jul; 11(6):353-9. PubMed ID: 20345886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-related oral lesions, demographic factors, clinical staging and anti-retroviral use.
    Ramírez-Amador V; Anaya-Saavedra G; Calva JJ; Clemades-Pérez-de-Corcho T; López-Martínez C; González-Ramírez I; Sierra-Madero J
    Arch Med Res; 2006 Jul; 37(5):646-54. PubMed ID: 16740437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells.
    Sternfeld T; Schmid M; Tischleder A; Mudra S; Schlamp A; Kost BP; Gruber R; Youle M; Bogner JR; Goebel FD
    Antivir Ther; 2007; 12(5):769-78. PubMed ID: 17713160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of Helicobacter pylori can facilitate immune reconstitution in HIV-1-infected immunological non-responders.
    Magen E; Elbirt D; Agmon-Levin N; Mishal J; Sthoeger Z
    Int J Infect Dis; 2010 Apr; 14(4):e322-7. PubMed ID: 19699671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death.
    Kaufmann GR; Elzi L; Weber R; Furrer H; Giulieri S; Vernazza P; Bernasconi E; Hirschel B; Battegay M;
    AIDS; 2011 Feb; 25(4):441-51. PubMed ID: 21206265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
    Palacios R; Senise J; Vaz M; Diaz R; Castelo A
    HIV Med; 2009 Mar; 10(3):157-62. PubMed ID: 19245537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral Service to HIV patients of low CD4 count in Seti Zonal Hospital.
    Paudel BN; Chaudhary SR; Sharma S; Dhungana GP; Paudel P
    JNMA J Nepal Med Assoc; 2009; 48(173):24-7. PubMed ID: 19529054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protecting the next generation--eliminating perinatal HIV-1 infection.
    Mofenson LM
    N Engl J Med; 2010 Jun; 362(24):2316-8. PubMed ID: 20554987
    [No Abstract]   [Full Text] [Related]  

  • 19. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of antiretroviral treatment in a South African program: a cohort study.
    Fairall LR; Bachmann MO; Louwagie GM; van Vuuren C; Chikobvu P; Steyn D; Staniland GH; Timmerman V; Msimanga M; Seebregts CJ; Boulle A; Nhiwatiwa R; Bateman ED; Zwarenstein MF; Chapman RD
    Arch Intern Med; 2008 Jan; 168(1):86-93. PubMed ID: 18195200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.